New FDA head needs to examine the accelerated approval program
World of DTC Marketing
OCTOBER 21, 2021
The analysis focused on Medicare Part B and Part D spending — which covers outpatient medical care and prescription drugs, respectively, — in 2017, 2018 and 2019, the researchers said. Between 2011 and 2018, cumulative spending on 44 FDA-approved oral targeted therapy drugs was $3.5
Let's personalize your content